Human ADA2 deficiency is characterized by the absence of an intracellular hypoglycosylated form of adenosine deaminase 2
Autor/innen
- L. Ehlers
- M. Wouters
- A. Hombrouck
- B. Pillay
- S. Delafontaine
- G. Bucciol
- M. Baggio
- M. Dzhus
- E. Francés Rabanal
- A. Damerau
- J. Neugebauer
- F. Ebstein
- M. Jacquemyn
- L. De Somer
- R. Schrijvers
- S. Vanderschueren
- D. Cassiman
- M. Kirchner
- P. Mertins
- M.F. Mashreghi
- T. Kallinich
- D. Daelemans
- P. Agostinis
- L. Moens
- I. Meyts
Journal
- bioRxiv
Quellenangabe
- bioRxiv
Zusammenfassung
Human deficiency of adenosine deaminase 2 (DADA2) is an autoinflammatory disease caused by pathogenic variants in ADA2 that lead to impaired deaminase activity. Recently, a lysosomal function of ADA2 has been proposed but an intracellular form of the protein has not yet been characterized. Here, we analyze protein expression of mutant ADA2 in human monocyte-derived macrophages from 10 DADA2 patients. We identify an intracellular low-molecular-weight (LMW) form of ADA2 that undergoes glycan trimming by α-mannosidases and is absent in DADA2 macrophages. Subcellular fractionation and immunofluorescence microscopy demonstrate that LMW-ADA2 is localized in the lysosomes. By overexpression of 34 ADA2 variants in HEK293T and U-937 cells, we show that absence of LMW-ADA2 strongly correlates with reduced deaminase activity and predicts variant pathogenicity. In conclusion, we describe a previously unreported intracellular hypoglycosylated form of ADA2 and establish the absence of this LMW-ADA2 as a cellular characteristic of DADA2. Thereby, we introduce a protein correlate of the recently described lysosomal form of ADA2.